- Publicerad
Redeye gives a short comment on today’s news that IRLAB has enrolledthe last patient in the ongoing phase IIb Pirepemat, in line with expectations
Redeye
Redeye gives a short comment on today’s news that IRLAB has enrolledthe last patient in the ongoing phase IIb Pirepemat, in line with expectations
Redeye